Momenta Pharmaceuticals

Momenta Claims Teva Gave Conflicting Information On Copaxone

pharmiweb.co.uk
14-Nov-2008
        

NEW YORK (Dow Jones)--Momenta Pharmaceuticals Inc. (MNTA) is accusing Teva Pharmaceutical Industries Ltd. (TEVA) of providing conflicting information to regulators to secure additional patents on its multiple sclerosis...

add comment

Momenta Pharmaceuticals to Present At Upcoming Conferences

primenewswire.com
05-Nov-2008 2 related
        

CAMBRIDGE, Mass., Nov. 5, 2008 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that management will...

add comment
                   

Momenta Pharmaceuticals Inc. (MNTA) reports 3rd Quarter ending September 2008 below estimates

pharmiweb.co.uk
04-Nov-2008 582 related
        

Conference Call: Momenta Pharmaceuticals Reports Financial Results for the Third Quarter of 2008 Momenta Pharmaceuticals, Inc. , a biotechnology company specializing in the detailed structural analysis of complex mixture drugs,...

add comment
                   

Momenta Pharma Q3 Loss Narrows - Update

pharmiweb.co.uk
03-Nov-2008
        

11/3/2008 9:12 AM ET (RTTNews) - Monday, Momenta Pharmaceuticals, Inc. (MNTA: News ), a biotechnology company specializing in the detailed structural analysis of complex mixture drugs, reported a narrower loss for the third...

add comment

Momenta Pharmaceuticals to Present At Oppenheimer 19th Annual Healthcare Conference

primenewswire.com
29-Oct-2008 7 related
        

CAMBRIDGE, Mass., Oct. 29, 2008 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Rick Shea,...

add comment